Skip to main content
. 2014 Jan 9;9(1):e84808. doi: 10.1371/journal.pone.0084808

Figure 2. Structures of HCV NS5B active site nucleotide inhibitor and NNIs targeting four allosteric sites used in this study.

Figure 2